Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

GATC Biotech AG. (12/3/14). "Press Release: GATC Biotech Lifts Next Generation Sequencing Services with NGSelect to the Next Level. Customers Benefit from a Modular Set-up Which Meets Frequent Scientific Needs". Constance.

Organisation Organisation GATC Biotech AG
  Group Eurofins (Group)
Products Product NGSelect sequencing service
  Product 2 InView™ sequencing service
Person Person Pohl, Peter (GATC Biotech AG 200611 CEO)
     


Power users gain even better access to sequencing capacity or can adapt cost-effective workflows


GATC Biotech today announced the launch of NGSelect – a novel modular system for next generation sequencing (NGS) applications for power users. It is a comprehensive solution that can be personalised by researchers, enabling them to either gain access to sequencing capacity alone or to combine additional services according to the modular concept.

”Apart the modular design of a sequencing project, one big benefit we see is that scientists can gain for a very interesting pricing access to sequence capacity. This provides them with a higher planning reliability and highly competitive delivery times, e.g. in times of shortages in sequencing capacities of their own in- house facilities.” said Peter Pohl, co-founder and CEO. “In addition, our innovative product is providing a new dimension of utility for our customers. Modules based on state-of-the-art technology and fully automated and streamlined workflows, offer highest flexibility and performance. That helps to accelerate NGS projects and increase data reliability, by lowering the project costs at once.”

NGSelect lifts NGS services to a new level complementing GATC Biotech’s Sequencing Solutions. It broadens the range of applications to enable scientists to use cost-efficient, standardised modules depending on their particular project requirements.

“Our InView™ portfolio of standardised products for NGS includes innovative solutions for the key areas our customers are working in. NGSelect is the logical and innovative step to complete our portfolio of Sequencing Solutions.” added Peter Pohl.


About GATC Biotech

GATC Biotech, a family-owned business, is one of the world´s leading service provider of DNA and RNA sequencing. For over two decades, the company has offered sequencing and bioinformatics solutions from single samples up to large scale projects. During this time, GATC Biotech has developed to a renowned brand, not only mastering a broad range of technologies and related downstream data analysis, but also processing millions of customer samples in professional quality and ready for diagnostic purposes.

The company offers true multiplatform sequencing using all leading sequencing technologies in its own labs. Its headquarter in Constance, Germany houses its ISO 17025 certified ‚Genome and Diagnostic Centre‘ with a focus on next and third generation sequencing. The European Custom Sequencing Centre located in Cologne, Germany focuses on GATC Biotech’s Sanger sequencing service. This advantageous location ensures rapid and efficient sample logistics. All laboratories have highly integrated and fully automated processing pipelines, ensuring full compliance with latest state-of-the-art quality standards.

Please visit www.gatc-biotech.com for more information.

   
Record changed: 2017-04-02

Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

More documents for Eurofins (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top